Maya Guglin: Clinical Trials

3 trials sponsored by Maya Guglin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 withdrawn. 2 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Terminated 1, Withdrawn 1
Phase 41Terminated 1

Follow Maya Guglin: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Low Sodium vs. Regular Diet in Patients Admitted for Heart Failure
Sodium Restricted Diet, Regular Diet - Heart Failure
Not applicableTerminatedMaya Guglin132016-11-012021-04-22
Effects of Metformin in Heart Failure Patients
Metformin, Subcutaneous (sliding scale) Insulin - Type 2 Diabetes Mellitus
Not applicableWithdrawnMaya Guglin2016-11-012018-11-23
Sildenafil in Heart Failure With Reactive Pulmonary Hypertension
Sildenafil, Placebo - Heart Failure With Reactive Pulmonary Hypertension
Phase 4TerminatedMaya Guglin332015-01-012019-11-07

Conditions studied

Diabetes Mellitus, Type 2 (1)  ·  Heart Failure (1)

Interventions

Diet (1)  ·  Diet, Sodium-Restricted (1)  ·  Injections, Subcutaneous (1)  ·  Insulin (1)  ·  Insulin Glargine (1)  ·  Metformin (1)  ·  Sildenafil Citrate (1)

Countries

United States (2)

Top investigators

Maya E Guglin, MD, PhD (1)

Results publications

PMID 27252841